It has been demonstrated that IL7R mutations activate downstream IL7R signaling independent of IL7 and promote cell transformation and tumor formation, indicating that IL7R exon 6 mutations are gain-of-function mutations (Kim et al., 2013). The gene discussed is IL7R; the disease is neoplasm.